{"id":34435,"date":"2024-05-15T12:00:00","date_gmt":"2024-05-15T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\/"},"modified":"2024-05-15T12:00:00","modified_gmt":"2024-05-15T12:00:00","slug":"pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/fr\/news\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\/","title":{"rendered":"Pr\u00e9-asthme : un concept utile ? Un article de l’EUFOREA – Partie 2"},"content":{"rendered":"
\n
\n
\n

Asthme \u00e9osinophilique \u00e0 d\u00e9but tardif<\/h2>\n

Le concept de pr\u00e9-diab\u00e8te a conduit \u00e0 la mise en place de mesures visant \u00e0 r\u00e9duire la progression de la maladie par l’identification des sujets \u00e0 risque de diab\u00e8te. Nous avons pr\u00e9c\u00e9demment examin\u00e9 l’id\u00e9e de pr\u00e9-asthme concernant l’asthme allergique et avons estim\u00e9 qu’en plus de la n\u00e9cessit\u00e9 d’am\u00e9liorer la sant\u00e9 de la population par de multiples mesures, y compris la r\u00e9duction de l’exposition aux allerg\u00e8nes et aux polluants et la pr\u00e9vention de l’ob\u00e9sit\u00e9, il existe plusieurs moyens sp\u00e9cifiques possibles pour r\u00e9duire le d\u00e9veloppement de l’asthme chez les personnes les plus \u00e0 risque (pr\u00e9-asthme). Le moyen le plus \u00e9vident est l’immunoth\u00e9rapie allerg\u00e9nique (ITA), qui, lorsqu’elle est administr\u00e9e pour la rhinite allergique (RA), dispose de preuves raisonnables pour soutenir la pr\u00e9vention de l’asthme chez les enfants (2), mais n\u00e9cessite \u00e9galement des \u00e9tudes suppl\u00e9mentaires en tant que pr\u00e9vention primaire. Dans ce second article, nous explorons les possibilit\u00e9s d’actions similaires dans l’asthme \u00e9osinophilique \u00e0 d\u00e9but tardif. <\/p>\n

Co-auteurs :<\/strong> Glenis Scadding, Claudia Gray, Diego Conti, Marinda McDonald, Vibeke Backer, Guy Scadding, Manuel Bernal-Sprekelsen, Eugenio De Corso, Zuzana Diamant, Claire Hopkins, Milos Jesenak, Pal Johansen, Jasper Kappen, Joaquim Mullol, David Price, Santiago Quirce, Sietze Reitsma, Sanna Toppila-Salmi, Brent Senior, Jacob Pontoppidan Thyssen, Ulrich Wahn, Peter W Hellings<\/p>\n

ACC\u00c8S LIBRE<\/strong><\/a><\/span><\/p>\n<\/div><\/div>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"

Asthme \u00e9osinophilique \u00e0 d\u00e9but tardif Le concept de pr\u00e9-diab\u00e8te a conduit \u00e0 la mise en place de mesures visant \u00e0 r\u00e9duire la progression de la maladie par l’identification des sujets \u00e0 risque de diab\u00e8te. Nous avons pr\u00e9c\u00e9demment examin\u00e9 l’id\u00e9e de pr\u00e9-asthme concernant l’asthme allergique et avons estim\u00e9 qu’en plus de la n\u00e9cessit\u00e9 d’am\u00e9liorer la sant\u00e9 de la population par de multiples mesures, y compris la r\u00e9duction de l’exposition aux allerg\u00e8nes et aux polluants et la pr\u00e9vention de l’ob\u00e9sit\u00e9, il existe plusieurs moyens sp\u00e9cifiques possibles pour r\u00e9duire le d\u00e9veloppement de l’asthme chez les personnes les plus \u00e0 risque (pr\u00e9-asthme). Le moyen le plus \u00e9vident est l’immunoth\u00e9rapie allerg\u00e9nique (ITA), qui, lorsqu’elle est administr\u00e9e pour la rhinite allergique (RA), dispose de preuves raisonnables pour soutenir la pr\u00e9vention de l’asthme chez les enfants (2), mais n\u00e9cessite \u00e9galement des \u00e9tudes suppl\u00e9mentaires en tant que pr\u00e9vention primaire. Dans ce second article, nous explorons les possibilit\u00e9s d’actions similaires dans l’asthme \u00e9osinophilique \u00e0 d\u00e9but tardif. Co-auteurs : Glenis Scadding, Claudia Gray, Diego Conti, Marinda McDonald, Vibeke Backer, Guy Scadding, Manuel Bernal-Sprekelsen, Eugenio De Corso, Zuzana Diamant, Claire Hopkins, Milos Jesenak, Pal Johansen, Jasper Kappen, Joaquim Mullol, David Price, Santiago Quirce, Sietze Reitsma, Sanna Toppila-Salmi, Brent Senior, Jacob Pontoppidan Thyssen, Ulrich Wahn, Peter W Hellings ACC\u00c8S LIBRE<\/p>\n","protected":false},"author":1,"featured_media":34442,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[266],"tags":[172,284],"class_list":["post-34435","news","type-news","status-publish","has-post-thumbnail","hentry","category-publications","tag-asthme","tag-publications"],"yoast_head":"\nPr\u00e9-asthme : un concept utile ? Un article de l'EUFOREA - Partie 2 - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/news\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pr\u00e9-asthme : un concept utile ? Un article de l'EUFOREA - Partie 2\" \/>\n<meta property=\"og:description\" content=\"Asthme \u00e9osinophilique \u00e0 d\u00e9but tardif Le concept de pr\u00e9-diab\u00e8te a conduit \u00e0 la mise en place de mesures visant \u00e0 r\u00e9duire la progression de la maladie par l’identification des sujets \u00e0 risque de diab\u00e8te. Nous avons pr\u00e9c\u00e9demment examin\u00e9 l’id\u00e9e de pr\u00e9-asthme concernant l’asthme allergique et avons estim\u00e9 qu’en plus de la n\u00e9cessit\u00e9 d’am\u00e9liorer la sant\u00e9 de la population par de multiples mesures, y compris la r\u00e9duction de l’exposition aux allerg\u00e8nes et aux polluants et la pr\u00e9vention de l’ob\u00e9sit\u00e9, il existe plusieurs moyens sp\u00e9cifiques possibles pour r\u00e9duire le d\u00e9veloppement de l’asthme chez les personnes les plus \u00e0 risque (pr\u00e9-asthme). Le moyen le plus \u00e9vident est l’immunoth\u00e9rapie allerg\u00e9nique (ITA), qui, lorsqu’elle est administr\u00e9e pour la rhinite allergique (RA), dispose de preuves raisonnables pour soutenir la pr\u00e9vention de l’asthme chez les enfants (2), mais n\u00e9cessite \u00e9galement des \u00e9tudes suppl\u00e9mentaires en tant que pr\u00e9vention primaire. Dans ce second article, nous explorons les possibilit\u00e9s d’actions similaires dans l’asthme \u00e9osinophilique \u00e0 d\u00e9but tardif. Co-auteurs : Glenis Scadding, Claudia Gray, Diego Conti, Marinda McDonald, Vibeke Backer, Guy Scadding, Manuel Bernal-Sprekelsen, Eugenio De Corso, Zuzana Diamant, Claire Hopkins, Milos Jesenak, Pal Johansen, Jasper Kappen, Joaquim Mullol, David Price, Santiago Quirce, Sietze Reitsma, Sanna Toppila-Salmi, Brent Senior, Jacob Pontoppidan Thyssen, Ulrich Wahn, Peter W Hellings ACC\u00c8S LIBRE\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/news\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\\\/\",\"name\":\"Pr\u00e9-asthme : un concept utile ? Un article de l'EUFOREA - Partie 2 - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Pre-Asthma20Part20220Teaser.png\",\"datePublished\":\"2024-05-15T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/news\\\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Pre-Asthma20Part20220Teaser.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Pre-Asthma20Part20220Teaser.png\",\"width\":1748,\"height\":1015},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/choisissez-votre-parcours\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Pr\u00e9-asthme : un concept utile ? Un article de l’EUFOREA – Partie 2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pr\u00e9-asthme : un concept utile ? Un article de l'EUFOREA - Partie 2 - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/news\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\/","og_locale":"fr_FR","og_type":"article","og_title":"Pr\u00e9-asthme : un concept utile ? Un article de l'EUFOREA - Partie 2","og_description":"Asthme \u00e9osinophilique \u00e0 d\u00e9but tardif Le concept de pr\u00e9-diab\u00e8te a conduit \u00e0 la mise en place de mesures visant \u00e0 r\u00e9duire la progression de la maladie par l’identification des sujets \u00e0 risque de diab\u00e8te. Nous avons pr\u00e9c\u00e9demment examin\u00e9 l’id\u00e9e de pr\u00e9-asthme concernant l’asthme allergique et avons estim\u00e9 qu’en plus de la n\u00e9cessit\u00e9 d’am\u00e9liorer la sant\u00e9 de la population par de multiples mesures, y compris la r\u00e9duction de l’exposition aux allerg\u00e8nes et aux polluants et la pr\u00e9vention de l’ob\u00e9sit\u00e9, il existe plusieurs moyens sp\u00e9cifiques possibles pour r\u00e9duire le d\u00e9veloppement de l’asthme chez les personnes les plus \u00e0 risque (pr\u00e9-asthme). Le moyen le plus \u00e9vident est l’immunoth\u00e9rapie allerg\u00e9nique (ITA), qui, lorsqu’elle est administr\u00e9e pour la rhinite allergique (RA), dispose de preuves raisonnables pour soutenir la pr\u00e9vention de l’asthme chez les enfants (2), mais n\u00e9cessite \u00e9galement des \u00e9tudes suppl\u00e9mentaires en tant que pr\u00e9vention primaire. Dans ce second article, nous explorons les possibilit\u00e9s d’actions similaires dans l’asthme \u00e9osinophilique \u00e0 d\u00e9but tardif. Co-auteurs : Glenis Scadding, Claudia Gray, Diego Conti, Marinda McDonald, Vibeke Backer, Guy Scadding, Manuel Bernal-Sprekelsen, Eugenio De Corso, Zuzana Diamant, Claire Hopkins, Milos Jesenak, Pal Johansen, Jasper Kappen, Joaquim Mullol, David Price, Santiago Quirce, Sietze Reitsma, Sanna Toppila-Salmi, Brent Senior, Jacob Pontoppidan Thyssen, Ulrich Wahn, Peter W Hellings ACC\u00c8S LIBRE","og_url":"https:\/\/www.euforea.org\/news\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/news\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\/","url":"https:\/\/www.euforea.org\/news\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\/","name":"Pr\u00e9-asthme : un concept utile ? Un article de l'EUFOREA - Partie 2 - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/news\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/news\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Pre-Asthma20Part20220Teaser.png","datePublished":"2024-05-15T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/news\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/news\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/news\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Pre-Asthma20Part20220Teaser.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Pre-Asthma20Part20220Teaser.png","width":1748,"height":1015},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/news\/pre-asthme-un-concept-utile-un-article-de-leuforea-partie-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/fr\/choisissez-votre-parcours\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/news\/"},{"@type":"ListItem","position":3,"name":"Pr\u00e9-asthme : un concept utile ? Un article de l’EUFOREA – Partie 2"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/#website","url":"https:\/\/www.euforea.org\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/34435","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/comments?post=34435"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/34435\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media\/34442"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media?parent=34435"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/categories?post=34435"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/tags?post=34435"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}